Novartis Investigative Site

Springfield, Oregon 97477

0 studies enrolling now · 5 studies all time

What they study most

Age-related Macular Degeneration, Cancer, Chronic Heart Failure (CHF), Multiple Sclerosis, Renal Cell Carcinoma (RCC), Secondary Progressive Multiple Sclerosis

Studies at this site

• Study to Assess the Efficacy and Safety of Brolucizumab 6mg Compared to Aflibercept 2 mg in a Treat-to-control Regimen (TALON) — Completed
• Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction — Completed
• Exploring the Efficacy and Safety of Siponimod in Patients With Secondary Progressive Multiple Sclerosis (EXPAND) — Completed
• Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies — Completed
• A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC) — Completed